Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs United Airlines Holdings Inc — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while United Airlines Holdings Inc trades at $107.46 (market cap $34.87B). The key difference: United Airlines Holdings Inc is far larger — about 2.8× Halozyme Therapeutics Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and United Airlines Holdings Inc for 46 Days on average.
| HALO | UAL | |
|---|---|---|
Market Cap | $12.58B | $34.87B |
Volume | 2,179,278 | 6,329,678 |
Sector | Health | Industrials |
52-Week High | $115.22 | $136.11 |
52-Week Low | $61.63 | $85.21 |
Typical Hold Time | 1 Days | 46 Days |
Enterprise Value | $14.49B | $51.90B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
United Airlines (UAL) trades at $107.44, down 2.48% on the day, reflecting near-term pressure amid a bearish technical signal. Fundamentally, the company shows strength with a low P/E of 10.06, robust ROE of 23.25%, and consistent earnings beats in recent quarters. Recent news highlights aggressive customer acquisition efforts targeting Delta and American Airlines' premium flyers, leveraging Starlink WiFi partnerships to enhance its competitive edge.
The outlook is mixed: strong analyst consensus (66% buy ratings) and a $158.10 price target suggest upside, but rising fuel costs and bearish technicals pose near-term risks. Earnings sustainability and market share gains from strategic moves are key catalysts, while volatility in travel demand remains a headwind.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
